Xiaolin Tong

Title: Innovations of Xiaolin Tong in Diabetes Treatment

Introduction

Xiaolin Tong is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach has led to the development of a unique pharmaceutical composition aimed at managing diabetes mellitus.

Latest Patents

Xiaolin Tong holds a patent for a pharmaceutical composition for treating diabetes and its process for preparation. This invention relates to methods for preparing a pharmaceutical composition that includes extracts from various crude drugs. The composition comprises 5-40 weight parts of Tianhuafen, 10-30 weight parts of Chaihu, 3-15 weight parts of Zhishi, 1-6 weight parts of Dahuang, 1-12 weight parts of Banxia, 3-15 weight parts of Huangqin, 1-12 weight parts of Huanglian, 3-15 weight parts of Baishao, and 5-20 weight parts of Wumei. Additionally, it may optionally include pharmaceutically acceptable excipients and can further comprise Shanzha. The invention also discloses four methods for preparing this pharmaceutical composition.

Career Highlights

Xiaolin Tong is associated with Tasly Pharmaceutical Group Co., Ltd., a prominent company in the pharmaceutical industry. His work focuses on innovative solutions for health challenges, particularly in diabetes management. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Xiaolin Tong has collaborated with notable colleagues, including Yonghong Zhu and Shuiping Zhou. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Xiaolin Tong's contributions to diabetes treatment through his innovative pharmaceutical compositions highlight the importance of research in addressing health issues. His work continues to inspire advancements in the field of medicine.